Page last updated: 2024-12-05

dibenz(b,f)(1,4)oxazepine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Dibenz(b,f)(1,4)oxazepine is a tricyclic heterocyclic compound that has been studied for its potential pharmacological activity. It serves as the core structure for a range of compounds with diverse biological properties. For instance, derivatives of dibenz(b,f)(1,4)oxazepine have been investigated as potential antipsychotics, antidepressants, and anticonvulsants. The synthesis of dibenz(b,f)(1,4)oxazepine derivatives often involves multi-step reactions, such as cyclization and ring-opening processes. The specific synthesis methods and reaction conditions can vary depending on the desired derivative. The pharmacological effects of dibenz(b,f)(1,4)oxazepine derivatives are thought to be related to their interaction with neurotransmitter receptors, such as dopamine, serotonin, and norepinephrine receptors. Further research is ongoing to explore the therapeutic potential of these compounds in treating various neurological and psychiatric disorders. The study of dibenz(b,f)(1,4)oxazepine derivatives is driven by their potential to provide new therapeutic options for patients with mental health conditions.'

Cross-References

ID SourceID
PubMed CID9213
CHEMBL ID1085100
SCHEMBL ID123289
MeSH IDM0110999

Synonyms (38)

Synonym
AKOS000425281
STL353334
dibenz[b,f]][1,4]oxazepine
cr (lacrimator)
brn 0743986
nsc 293779
dibenz(b,f)(1,4)oxazepine
wln: t c676 bo inj
nsc-293779
257-07-8
ea 3547
dibenz[b,4]oxazepine
dibenz(b,4]oxazepine
OPREA1_455217
benzo[b][1,4]benzoxazepine
HMS1726B05
CHEMBL1085100 ,
dibenzo[b,f][1,4]oxazepine
dibenz[b,f][1,4]oxazepine
bdbm50318511
c1q77a87v1 ,
agent cr
unii-c1q77a87v1
hsdb 7598
cr gas
2-oxa-9-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene
MS-2513
dibenz(b,f)(1,4)oxazepine [hsdb]
benzo[b][1,5]benzoxazepine
gtpl6472
SCHEMBL123289
DTXSID8059764
dibenz[b,f]-1,4-oxazepine
dibenzo[b,f][1,4]oxazepine #
dibenz(b,f)-1,4-oxazepin
mfcd00449255
Q417922
CCG-274908
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily A member 1Homo sapiens (human)EC50 (µMol)0.10290.00033.166210.0000AID482136; AID516893
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (17)

Processvia Protein(s)Taxonomy
monoatomic ion transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellular calcium ion homeostasisTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to coldTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to xenobiotic stimulusTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic cyclic compoundTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to hydrogen peroxideTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (5)

Processvia Protein(s)Taxonomy
calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
temperature-gated cation channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
plasma membraneTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
stereocilium bundleTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID516895Agonist activity at human TRPA1 expressed in T-REx-HEK293 cells assessed as concentration required to incapacitate 50% of the population exposed to tear gas2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Analogues of morphanthridine and the tear gas dibenz[b,f][1,4]oxazepine (CR) as extremely potent activators of the human transient receptor potential ankyrin 1 (TRPA1) channel.
AID482136Activation of human TRPA1 channel2010Journal of medicinal chemistry, Jul-22, Volume: 53, Issue:14
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
AID516901Agonist activity at TRPM82010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Analogues of morphanthridine and the tear gas dibenz[b,f][1,4]oxazepine (CR) as extremely potent activators of the human transient receptor potential ankyrin 1 (TRPA1) channel.
AID516900Agonist activity at human TRPV12010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Analogues of morphanthridine and the tear gas dibenz[b,f][1,4]oxazepine (CR) as extremely potent activators of the human transient receptor potential ankyrin 1 (TRPA1) channel.
AID516894Agonist activity at human TRPA1 expressed in T-REx-HEK293 cells assessed as threshold concentration after 1 min2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Analogues of morphanthridine and the tear gas dibenz[b,f][1,4]oxazepine (CR) as extremely potent activators of the human transient receptor potential ankyrin 1 (TRPA1) channel.
AID516893Agonist activity at human TRPA1 expressed in T-REx-HEK293 cells assessed as increase of intracellular calcium level by FDSS assay2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Analogues of morphanthridine and the tear gas dibenz[b,f][1,4]oxazepine (CR) as extremely potent activators of the human transient receptor potential ankyrin 1 (TRPA1) channel.
AID1346556Human TRPA1 (Transient Receptor Potential channels)2008Toxicology and applied pharmacology, Sep-01, Volume: 231, Issue:2
Tear gasses CN, CR, and CS are potent activators of the human TRPA1 receptor.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (35.29)18.7374
1990's3 (17.65)18.2507
2000's3 (17.65)29.6817
2010's5 (29.41)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.37 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (10.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]